R E Margolis

431 total citations
2 papers, 351 citations indexed

About

R E Margolis is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Cell Biology. According to data from OpenAlex, R E Margolis has authored 2 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Molecular Biology, 1 paper in Pediatrics, Perinatology and Child Health and 1 paper in Cell Biology. Recurrent topics in R E Margolis's work include Microtubule and mitosis dynamics (1 paper), Pharmaceutical Economics and Policy (1 paper) and Pharmaceutical studies and practices (1 paper). R E Margolis is often cited by papers focused on Microtubule and mitosis dynamics (1 paper), Pharmaceutical Economics and Policy (1 paper) and Pharmaceutical studies and practices (1 paper). R E Margolis collaborates with scholars based in United States. R E Margolis's co-authors include D K Palmer and Kathleen O'Day and has published in prestigious journals such as The Journal of Cell Biology and PubMed.

In The Last Decade

R E Margolis

2 papers receiving 348 citations

Peers

R E Margolis
Comparison fields: 5 of 30
  • Molecular Biology 314
  • Plant Science 254
  • Cell Biology 140
  • Genetics 39
  • Epidemiology 10
Replace Teruaki Okada with:
Teruaki Okada Japan
Aaron A. Van Hooser United States
Quan‐wen Jin China
Harald Eggert Germany
Luis P. Valente Portugal
Elizabeth O. Shuster United States
Soni Lacefield United States
Tim Olsson Sweden
Norihiko Nakazawa Japan
Ana-Maria Farcas Switzerland
Teruaki Okada Japan View profile →
Citations per field, relative to R E Margolis
R E Margolis · 1×
Citations per year, relative to R E Margolis
R E Margolis · 1×

Countries citing papers authored by R E Margolis

Since Specialization
Citations

This map shows the geographic impact of R E Margolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Margolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Margolis more than expected).

Fields of papers citing papers by R E Margolis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R E Margolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Margolis. The network helps show where R E Margolis may publish in the future.

Co-authorship network of co-authors of R E Margolis

This figure shows the co-authorship network connecting the top 25 collaborators of R E Margolis. A scholar is included among the top collaborators of R E Margolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R E Margolis. R E Margolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
# Work Indexed citations
1
Off-label uses of drugs and medical devices: should the FDA crack down?
1
2 350

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026